Related Experiment Video

Updated: Mar 30, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
11:17

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses

Published on: August 30, 2018

13.6K

Major publications in the critical care pharmacotherapy literature: January-December 2014

Sarah A Day1, Michaelia Cucci1, Molly E Droege1

  • 1Sarah A. Day, Pharm.D., BCPS, is Clinical Pharmacist, Critical Care, Doctors Hospital OhioHealth, Columbus, OH. Michaelia Cucci, Pharm.D., BCPS, is Pharmacy Clinical Specialist-Critical Care, Pharmacy Department, Lakewood Hospital, Lakewood, OH. Molly E. Droege, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Surgery, Orthopedics, and Trauma, UC Health-University of Cincinnati Medical Center, Cincinnati, OH. Jenna M. Holzhausen, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Critical Care, Beaumont Hospital, Royal Oak, MI. Bridgette Kram, Pharm.D., BCPS, is Clinical Pharmacist, Department of Pharmacy, Duke University Medical Center, Durham, NC. Shawn Kram, Pharm.D., BCPS, is Clinical Pharmacist, Medical and Cardiothoracic ICUs, Department of Pharmacy, Duke University Medical Center. Mehrnaz Pajoumand, Pharm.D., is Clinical Specialist, Trauma Critical Care, University of Maryland Medical Center, Baltimore. Christine R. Parker, Pharm.D., BCPS, is Clinical Pharmacy Specialist, Surgical Critical Care, New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, NY. Mona K. Patel, Pharm.D., is Clinical Pharmacy Manager, Surgical Intensive Care Unit, New York-Presbyterian Hospital, Columbia University Medical Center, New York. Gregory J. Peitz, Pharm.D., is Adult Intensive Care Pharmacy Coordinator, Nebraska Medicine, Nebraska Medical Center, Omaha. Alia Poore, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Critical Care, Fairview Hospital, Cleveland, OH. Charles J Turck, Pharm.D., BCPS, is President and CEO, ScientiaCME, LLC, and Scientia Perpetuam, LLC, Highwood, IL. Megan A. Van Berkel, Pharm.D., BCPS, is Clinical Pharmacy Specialist-Emergency Department, Department of Pharmacy, Methodist LeBohneur Healthcare Methodist University Hospital, Memphis, TN. Adrian Wong, Pharm.D., BCPS, is Critical Care Clinical Pharmacist, MountainView Hospital, Las Vegas, NV. Amanda Zomp, Pharm.D., BCPS, is Clinical Pharmacist, Critical Care, Department of Pharmacy Services,

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|November 7, 2015
PubMed
Abstract

More Related Videos

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.3K
Intracranial Pharmacotherapy and Pain Assays in Rodents02:26

Intracranial Pharmacotherapy and Pain Assays in Rodents

Published on: April 9, 2019

6.0K

Related Concept Videos

Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.3K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
71
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
809
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
400
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
317
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
347